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Abstract
Aims: To characterize in vitro the ability of human Lactobacillus strains to
inhibit the adhesion, to displace and to compete with clinically isolated
Candida strains.
Methods and Results: Three types of assays were performed to determine the
inhibitory effect of Lactobacillus plantarum 319, Lactobacillus rhamnosus IMC
501, Lactobacillus paracasei IMC 502 and a specific probiotic combination
(SYNBIO) on adhesion of Candida pathogens to HeLa cells: blockage by
exclusion (lactobacilli and HeLa followed by pathogens), competition
(lactobacilli, HeLa and pathogens together) and displacement (pathogens and
HeLa followed by the addition of lactobacilli). Bacterial adhesion to HeLa was
quantified by microscopy after May-Gr€unwald/Giemsa stain. The inhibition
results highlight a significant (P < 005) competition of the considered
probiotics against all the Candida strains. The results suggest that the probiotic
strains used in this study could prevent colonization of the urogenital tract by
relevant pathogens such as Candida strains through barrier and interference
mechanisms (mainly displacement and competition), but the degree of
inhibition of adhesion was bacterial strain-dependent.
Conclusions: The results support the potential of these Lactobacillus probiotic
strains as anti-infective agents in the vagina and encourage further studies
about their capacity to prevent and manage urogenital tract infections in
females.
Significance and Impact of the Study: To optimize the defensive properties of
the vaginal microbiota, improving the health of many women by probiotic
intervention.
Introduction
It has long been understood that interactions between
microbes and the host vagina have major implications for
the well-being of the female. The microbial species that
inhabit the vaginal tract play an important role in the
maintenance of health and prevention of infection. Under
physiological conditions, the vagina primarily harbours
lactobacilli which ideally confer, in mutualism with the
vaginal epithelium, colonization resistance to other
micro-organisms, thereby preventing ascending or sys-
temic infection. The most common Lactobacillus species
are Lact. iners, Lact. crispatus, Lact. gasseri and Lact. jene-
senii, followed by Lact. acidophilus, Lact. fermentum,
Lact. plantarum, Lact. brevis, Lact. casei, Lact. vaginalis,
Lact. delbrueckii, Lact. salivarius, Lact. reuteri and Lact.
rhamnosus (Vasquez et al. 2002; Anukam et al. 2005). All
the factors such as hormonal changes (particularly
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oestrogen), vaginal pH and glycogen content can affect
the colonization of the lactobacilli in the vagina (Burton
and Reid 2002). Menstrual cycle can also cause hormonal
changes.
In women, the depletion of vaginal lactobacilli leads to
an overgrowth of diverse aerobic, anaerobic and
microaerophilic species. The long-term efficiency of
antimicrobial treatment is often limited by relapse, most
likely due to an inability to re-establish the normal Lacto-
bacillus-dominated vaginal flora.
There have been several attempts to restore the normal
vaginal flora by re-colonizing with lactobacilli (Cribby
et al. 2008; Borges et al. 2014). However, the correct
choice of Lactobacillus strains has not always been used.
In this regard, probiotics provide a health benefit to
the host and are promoted as alternatives for the treat-
ment and prevention of infectious diseases and other
conditions. A recent important area of probiotic research
is in the management of vaginally acquired infections
(Borges et al. 2014). Several Lactobacillus species produce
compounds that kill or inhibit the growth of vaginally
acquired pathogens (Kaewsrichan et al. 2006). Other lac-
tobacilli reduce the adherence of pathogens to urogenital
epithelial cells in culture (Osset et al. 2001).
Probiotics have been documented to be beneficial in
curing vaginal infections as well as reducing its recurrence
and have been administered both orally and vaginally
(Senok 2009). Mechanisms through which probiotics play
a role in bacterial vaginitis treatment include: (i) occupa-
tion of specific adhesion sites at the epithelial surface of
the urinary tract, (ii) maintenance of a low pH and pro-
duction of antimicrobial substances like acids, hydrogen
peroxide and bacteriocins, (iii) degradation of polyamines
and (iv) the production of surfactants with anti-adhesive
properties (Goldin and Gorbach 2008).
Recent advances are concentrated on the characteriza-
tion and development of probiotics formulation to
reduce, inhibit or, in same case, cure genital infection,
especially vaginal yeast infection. The problem is corre-
lated with the fact that fungi have emerged as major
causes of human disease, especially among the immune-
compromised and hospitalized people (McNeil et al.
2001; Eggimann et al. 2003; Fridkin 2005). Numerous
factors have contributed to the increase in fungal infec-
tions, such as mucosal or cutaneous barrier disruption,
defects in the number and function of neutrophils or in
cell-mediated immunity, metabolic dysfunction and
extremes of age, but one of the most important factor is
the increase in the use of broad-spectrum antibiotics
(Pfaller and Diekema 2007). The last factor is also
responsible for the increase of the antibiotics resistance of
fungi and hence, for the problem related to the treatment
of vaginal yeast infection (Walsh et al. 2004). In fact,
today, it is not only difficult to cure this disease but also
to reduce the recurrence of disease in time, without con-
sidering the enormous economic weight that the diagno-
sis and treatment of the pathology have on the public
health care. So, alternative therapeutic agents need to be
sought, and it has been suggested that the administration
of lactobacilli can restore ecological balance in the vagina
by controlling the infectivity of pathogenic microbes
(Mailander-Sanchez et al. 2011).
In a previous study (Verdenelli et al. 2014), we investi-
gated how a collection of wild-type lactobacilli isolated
from human intestinal tract of older people adhere to
vaginal human cancerogenic cells (HeLa) and exert a
protective activity against Candida strains.
Some of these lactobacilli demonstrated promising
properties such as adhesion, coaggregation abilities,
antimicrobial activity against pathogenic Candida strains,
technological characteristics that make them good
candidates for the realization of formulations suitable for
vaginal health.
The purpose of this study was to assess the capacity of
previously selected Lactobacillus strains, already proved to
adhere to vaginal epithelium, to remove or inhibit the
adhesion of Candida species from vaginal cells with the
aim of demonstrating the ability of these bacteria to
reduce pathogen infections and compete for the same
environment.
Materials and methods
Microbial strains, cell line and growth condition
The Lactobacillus strains used in this study (Table 1) were
isolated from older participants of Italy during an EU
project named Crownalife (Silvi et al. 2003). Lactobacillus
rhamnosus IMC 501 and Lactobacillus paracasei IMC
502 were characterized as probiotics in previous studies
(Verdenelli et al. 2009, 2011). Lactobacillus plantarum 319
was characterized as probiotic (Coman et al. 2014a,b)
and the deposit in DSMZ collection is currently ongoing.
All the strains have been shown to adhere to HeLa cells
(Verdenelli et al. 2014). Candida strains (Table 1) were
clinically isolated from human vagina and supplied by
Istituto Superiore di Sanita in Rome. Lactobacilli were
grown in MRS (de Man, Rogosa, Sharpe) broth (Oxoid,
Basingstoke, UK), whereas Candida strains were grown in
Sabouraud (SAB) dextrose medium (Oxoid). All the
strains were grown aerobically at 37°C. The HeLa cell line
was grown in Dulbecco’s Minimal Essential Medium
(DMEM; PAA Laboratories GmbH, Pasching, Austria)
supplemented with 10% foetal bovine serum (FBS), 1%
L-glutamine and 1% antibiotic/antimycotic. Cells were
cultured at 37°C in a humidified (95%) atmosphere 5%
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CO2 and subcultured twice per week and the medium
changed every 3 days.
Adhesion test
Three types of assays were performed to study the ability
of lactobacilli to block the adherence of Candida strains
to HeLa cells: blockage by exclusion, by displacement or
by competition.
Exclusion test
To assess the capacity of lactobacilli strains to influence the
adherence of pathogens to vaginal human cells, interfer-
ence experiments were performed against Candida clinical
isolates. Adhesion reaction was performed using 6-well cul-
ture plate containing a sterile coverslip in each well. Each
well was then added with 2 ml of HeLa cell suspension at a
concentration of 4 9 105 cells ml1 and incubated in a
5% CO2 atmosphere at 37°C. After 48 h, when the cells
were grown to approx. 60% confluence, they were washed
twice with PBS and inoculated with 1 ml of lactobacilli
suspension at a concentration of 15 9 109 cells ml1. The
plates were then incubated for 1 h at 37°C in a 5% CO2
atmosphere to allow the adhesion of bacteria on cells. After
1 h, the cells were washed twice with PBS to remove all
nonadhering bacteria and again inoculated, but in this case
with Candida strains in the same experimental condition
(15 9 109 cells ml1). At the end, the cells were washed,
stained with the May-Gr€unwald/Giemsa stain and analysed
under the microscope (1009; Leitz Laborlux 12 micro-
scope, Ernst Leitz, Wetzlar GmbH, Germany). Further,
each HeLa cell was scored for the presence and number of
bacteria and Candida strains attached, and a number of
100 cells was checked for micro-organism adhesion.
Displacement test
The displacement test evaluates the ability of the Lacto-
bacillus strains to displace the already-adhered pathogens,
and occurs with the same protocols of the exclusion test;
but in this case, the sequence of the inoculation was
reversed, which implies that the HeLa cells were inocu-
lated first with Candida strains and then with lactobacilli.
Competition test
Competitive exclusion of the pathogens by tested probi-
otics was determined as described previously, but in this
case, lactobacilli and Candida were added together to
HeLa cells incubated for 1 h at 37°C in a 5% CO2 atmo-
sphere.
The results of the three conditions (i.e. exclusion, dis-
placement and competition) were expressed as the mean
number of Candida cells per HeLa cell and compared
with the number obtained in the adhesion without lacto-
bacilli (control value). The control values were taken as
100% of adhesion and the inhibition of pathogens adher-
ence was calculated by subtracting each adhesion percent-
age from their corresponding value.
Data analysis, calculations and statistical analysis
The results of exclusion, displacement and competition
assay are expressed as the average of three independent
experiments. Significant differences between mean values
were determined by Tukey’s test after one-way analysis of
variance ANOVA (one-way ANOVA) using GRAPHPAD PRISM
5.1 program (GraphPad Software, San Diego, CA, USA).
A P-value <005 was considered statistically significant.
Results
The three lactobacilli (319, IMC 501, IMC 502) and
the SYNBIO (IMC 501–IMC 502 combination) (Syn-
biotec Srl, Italy) were able to exclude, compete with and
displace all the Candida strains tested. The effect was
dependent on the each probiotic strain and the pathogen
assayed (Table 2, Fig. 1). The Lactobacillus strains tested
showed a broad range of pathogen exclusion. The adhe-
sion of Candida albicans ATCC 14503 and C. albicans
ISS1 was significantly reduced by all strains. No signifi-
cant differences were observed in the exclusion of Can-
dida glabrata ISS3 and Candida krusei ISS4 by all strains.
The adhesion of all the pathogens tested were signifi-
cantly reduced by competition by all the lactobacilli rang-
ing from 249 to 897% depending on the pathogen and
the Lactobacillus strain. Degree of displacement of
adhered Candida strains by all lactobacilli was significant
Table 1 Lactobacillus and Candida strains used in this study
Strain Origin
Lactobacillus plantarum 319 Intestinal isolate
Lactobacillus rhamnosus IMC 501 Intestinal isolate
Lactobacillus paracasei IMC 502 Intestinal isolate
SYNBIO*
Candida albicans ATCC 14053 Culture collection
Candida albicans ISS1 Clinical isolate
Candida albicans ISS2 Clinical isolate
Candida albicans ISS7 Clinical isolate
Candida glabrata ISS3 Clinical isolate
Candida krusei ISS4 Clinical isolate
Candida parapsilosis ISS5 Clinical isolate
Candida tropicalis ISS6 Clinical isolate
*Combination 1 : 1 of Lact. rhamnosus IMC 501 and Lact. paraca-
sei IMC 502.
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for C. albicans ISS1, ISS2, ISS7, C. glabrata ISS3 and
Candida parapsilosis ISS5. No displacement was observed
with C. albicans ATCC 14503, in particular, Lact. plan-
tarum 319 and SYNBIO showed the highest inhibition
percentage against Candida strains in the three types of
assays. It is interesting to note that in several cases, the
SYNBIO combination enhance the inhibition ability of
the single strains Lact. rhamnosus IMC 501 and
Lact. paracasei IMC 502. This was demonstrated for
C. krusei ISS4, C. parapsilosis ISS5, Candida tropicalis
ISS6 and C. albicans ISS7 in the exclusion test, for C. al-
bicans ISS2, C. glabrata ISS3, C. krusei ISS4 and C. para-
psilosis ISS5 in the competition test and for C. glabrata
ISS3 in displacement test. In general, the results shown in
Table 2 demonstrated that the exclusion profiles for Can-
dida strains by lactobacilli were very different from those
of competition and displacement. Degrees of exclusion
were generally much lower than the degree of inhibition
achieved by competition and displacement. This is true
for both strains of C. albicans and for non-albicans
strains. Figure 1 shows the effect of the tested Lactobacil-
lus strains on the attachment of the different Candida
strains to HeLa cells under the conditions of exclusion,
displacement and competition.
The Lactobacillus strains tested were able to exclude,
compete with and displace the Candida strains to differ-
ent degrees (Fig. 2). The main mechanisms of action that
determined a significant reduction in Candida were dis-
placement and competition, in particular against non-al-
bicans strains. Lactobacillus plantarum 319 was also able
to significantly reduce the attachment of Candida strains,
except for C. krusei ISS4, with the exclusion mechanisms.
Discussion
The rationale for replenishing the vagina with non-
pathogenic organisms, such as probiotic lactobacilli, has
been recently reviewed (Homayouni et al. 2014). The
effectiveness of treatment is certainly related to the ability
of lactobacilli to adhere to the vaginal mucosa and exert
an antiphatogenic activity. The capacity to adhere to
human epithelial cells, as well as the antagonism towards
pathogen establishment is also considered as crucial by
the FAO/WHO for the in vitro evaluation of potential
probiotic candidates (FAO/WHO, 2006). The Lactobacil-
lus strains used in this study have previously shown adhe-
sive properties (Verdenelli et al. 2014) and antagonistic
effects against urogenital pathogens (Coman et al. 2014a,b).
In the present study, we assessed their capability of inter-
fering with the adhesion of vaginal pathogens, such as
Candida strains in a model human cell line. In the healthy
urogenital tract of adult females, it is supposed that the
(a) (b)
(c) (d) (e)
Figure 1 Adherence of Lactobacillus plantarum 319 (a) and Candida glabrata ISS3 (b) to vaginal epithelial cells (HeLa cells) as observed by light
microscope after May-Grunwald/Giemsa stain under condition of exclusion (c) displacement (d) and competition (e).
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indigenous lactobacilli exclude the colonization of patho-
genic bacteria by occupying or masking (by steric hin-
drance) their potential binding sites in the mucosa (Chan
et al. 1984; Spencer and Chesson 1994). However, in a
depleted lactobacilli environment, such as an infected uro-
genital tract, it should be expected that exogenous probi-
otic lactobacilli have the capacity to compete for the same
receptors and displace previously attached pathogens
(Reid 2000). Therefore, we investigated the blockage of
Candida pathogen adherence by lactobacilli, under three
possible interactive mechanisms: exclusion by adhered
Lactobacillus strains, displacement of adhered pathogens
and competition for receptor sites (inhibition test). In the
exclusion assays, we found enormous differences among
the Lactobacillus strains in their ability to block the adher-
ence of Candida strains to HeLa cells. Moreover, the same
Lactobacillus displayed different blocking capacity accord-
ing to the Candida strain studied. Lactobacillus plantarum
319 showed the greatest blocking activity by exclusion
mechanism against six of eight Candida strains tested
including all the C. albicans strains which are the most
frequent agents causing vaginal infection (Hani et al.
2015). No strain was able to significantly inhibit by exclu-
sion mechanism, the adhesion of C. glabrata and C. krusei
strains, which are non-albicans Candida (NAC) species
that cause 35  65% of all candidaemias in the general
patient population (Krcmery and Barnes 2002). All the
lactobacilli tested demonstrated the ability to strongly
reduce the adherence of invading yeast cells in the compe-
tition assay. The degree of competition is determined by
the affinity of adhesins on the respective bacterial surfaces
for the specific receptors that they are competing for; or
their relative positions in the case of stearic hindrance
(Lee et al. 2003). Moreover, the ability to significantly
inhibit the attachment of pathogens by displacement indi-
cates that affinity of lactobacilli for the specific receptors is
higher than that of the pathogenic strain tested, as shown
by Kaewsrichan et al. (2006). SYNBIO combination
(Lact. rhamnosus IMC 501 and Lact. paracasei IMC
502) was able to significantly reduce the attachment of
C. glabrata to HeLa cells by competition and displacement
at a higher percentage than the two strains taken individu-
ally. This specific synergy of the two strains, already high-
lighted in other studies on adhesion (Verdenelli et al.
2009, 2014), may be of interest in situations in which the
individual strains are not able to counter specific patho-
gens. This is the case of C. parapsilosis ISS5: neither
Lact. rhamnosus IMC 501 nor Lact. paracasei IMC 502
were able to significantly inhibit the attachment to HeLa
while SYNBIO did so. The results of this work are even
more interesting because clinically isolated Candida strains
were tested, some of which are among other resistant
strains to imidazole antifungals.
It is important to emphasize that a balanced vaginal
microflora results in an unfavourable environment to the
attraction of pathogenic bacteria. This implies that lacto-
bacilli with a significant ability to block pathogens with
exclusion mechanism are certainly valid to maintain vagi-
nal health. By contrast, in patients with recurrent vaginal
infections, lactobacilli with high capacity to compete and/
or displace previously attacked pathogens could definitely
result of greater impact. This study has shown that the
same strain of Lactobacillus can exert various activities of
inhibition in relation to the pathogen tested. This implies
and reinforces the concept and the importance of proper
probiotics characterization. Since probiotic properties are
strain specifics, it would be interesting to use more than
one probiotic strain in the same vaginal product. Our study
demonstrated that Lact. plantarum 319 and SYNBIO have
the most significant (P < 005) interference activity on
vaginal pathogens using different mechanisms of action.
The use of a combination of these probiotic strains in a
vaginal formulation might be effective not only as preven-
tion in healthy women but also in the reduction of vaginal
colonization by potential pathogenic bacteria and yeasts.
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